Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 21 August 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Enhancing the diagnosis of gastro-esophageal reflux disease

Diagnosis of gastro-esophageal reflux disease is enhanced by adding esophageal histology and excluding epigastric pain, reports a study published in the Alimentary Pharmacology & Therapeutics.

News image

The diagnosis of gastro-esophageal reflux disease (GERD) in clinical practice is limited by the sensitivity and specificity of symptoms and diagnostic testing.

Professor Vakil and colleagues from Wisconsin, USA determined if adding histology as a criterion and excluding patients with epigastric pain enhances the diagnosis for GERD.

Patients with frequent upper gastrointestinal symptoms who had not taken a proton pump inhibitor in the previous 2 months, and who had evaluable distal esophageal biopsies were included. 

Epithelial hyperplasia was identified when total epithelial thickness was at least 430 μm. 

The team's investigation-based GERD criteria included presence of erosive esophagitis, pathological esophageal acid exposure, and/or positive symptom–acid association probability. 

Adding epithelial hyperplasia as a criterion increased the diagnosis of GERD to 67%
Alimentary Pharmacology & Therapeutics
The researchers assessed symptoms using the Reflux Disease Questionnaire, and a pre-specified checklist.

Overall, the team found that 55% of the 231 included patients met investigation-based GERD criteria, and 84% met symptom-based criteria. 

Epithelial hyperplasia was present in 89 individuals, of whom 69% met investigation-based criteria, and 93% met symptom-based criteria. 

The researchers noted that adding epithelial hyperplasia as a criterion increased the number of patients diagnosed with GERD on investigation to 67%. 

The proportion of patients with a symptom-based GERD diagnosis who met investigation-based criteria including epithelial hyperplasia was significantly greater when concomitant epigastric pain was absent than when it was present.

Professor Vakil's team comments, "Histology increases diagnosis of GERD, and should be performed when clinical suspicion is high and endoscopy is negative."

"Excluding patients with epigastric pain enhances sensitivity for the diagnosis of GERD."

Aliment Pharmacol Ther 2017: 45(10): 1350–1357
11 July 2017

Go to top of page Email this page Email this page to a colleague

 21 August 2017 
Improving medication adherence in IBD
 21 August 2017 
Treatments for chronic idiopathic constipation
 21 August 2017 
Ethnic disparities for chronic Hep C survival
 18 August 2017 
Proteomic analysis of IBD
 18 August 2017 
Pediatric intestinal failure
 18 August 2017 
Anti-TNF treatment and bowel resection in Crohn's
 17 August 2017 
Outcomes of ulcerative colitis patients undergoing pouch surgery
 17 August 2017 
Mortality in patients with asymptomatic pancreatic cystic neoplasms
 17 August 2017 
Survival after primary tumor resection in advanced colorectal cancer
 16 August 2017 
Assessment of seronegative villous atrophy
 16 August 2017 
Appendectomy and colectomy risk in ulcerative colitis
 16 August 2017 
Gluten sensitivity and celiac disease
 15 August 2017 
Infliximab and treatment failure during maintenance
 15 August 2017 
Genetic in idiopathic pancreatitis
 15 August 2017 
Genetic factors and tobacco in IBD
 14 August 2017 
Per oral endoscopic myotomy
 14 August 2017 
Early colonoscopy and symptomatic colorectal cancer
 14 August 2017 
Ethnic disparities and Hep C survival
 11 August 2017 
Ledipasvir and sofosbuvir in treatment-naïve Hep C
 11 August 2017 
EBV DNA to screen for nasopharyngeal cancer
 11 August 2017 
Direct acting antivirals and mixed cryoglobulinemia
 10 August 2017 
Routine preoperative laboratory tests for elective surgery
 10 August 2017 

Whole-genome sequencing in primary care

 10 August 2017 
Mortality in cirrhosis
 09 August 2017 
Anticoagulants in cirrhosis
 09 August 2017 
IBS with extraintestinal somatic and psychological symptoms
 09 August 2017 
Low birthweight and pediatric NAFLD
 08 August 2017 
Prior Barrett’s diagnosis and esophageal cancer survival
 08 August 2017 
Imaging index for fistulizing Crohn's
 08 August 2017 
Statin use after colon cancer
 07 August 2017 
Contraindications of biologic therapies in IBD
 07 August 2017 
Predicting clinical outcome in colorectal cancer
 07 August 2017 
Future burden of esophageal cancer
 04 August 2017 
Internet decision-making resources for ulcerative colitis surgery
 04 August 2017 
Distal findings and proximal colorectal neoplasia
 04 August 2017 
CT colonography vs flexible sigmoidoscopy
 03 August 2017 
Bloating and abdominal distension
 03 August 2017 
Predictors of colectomy in ulcerative colitis
 03 August 2017 
Treatment for sensitized transplant patients
 02 August 2017 
Preventing reactivation of Hep B
 02 August 2017 
Improving medication adherence in IBD
 02 August 2017 
Multiply recurrent C. difficile in the USA
 01 August 2017 
Coping with IBD
 01 August 2017 
Hepatocellular carcinoma in autoimmune hepatitis
 01 August 2017 
Anti-TNF treatment in Crohn's disease
 31 July 2017 
Global HCV incidence and mortality elimination targets
 31 July 2017 
Diagnosing GERD
 31 July 2017 
Diagnostic accuracy of severe liver fibrosis in patients with NAFLD
 28 July 2017 
Low FODMAP diet in IBS
 28 July 2017 
IBD patient–centered medical home
 28 July 2017 
Excluding NAFLD in the general population
 27 July 2017 
H. pylori infection and preeclampsia
 27 July 2017 
Colorectal cancer increases in developed and developing regions
 27 July 2017 
Anger in HIV-HCV co-infected patients
 26 July 2017 
Treating chronic pancreatitis
 26 July 2017 
Colorectal cancer screening
 26 July 2017 
Factors that influence H. pylori gastritis
 25 July 2017 
Influencing insulin resistance in patients with NAFLD
 25 July 2017 
IBD in immigrants from Cuba to the USA

 25 July 2017 
Split-dose bowel preparation for colonoscopy

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us